New Insights into Genetic Factors in Parkinson's Disease
Study examines the role of genes in Parkinson's and viral infections.
― 5 min read
Table of Contents
Parkinson's disease (PD) is a common brain disorder that affects movement. It happens when a specific type of brain cell, called dopaminergic neurons, slowly die. These neurons are mainly found in a part of the brain called the Substantia nigra. The exact cause of PD is still not clear, but it's believed that a mix of genes and things in our environment, like Infections, can play a part.
Some research suggests that the problems of PD might begin outside the brain, particularly in the nose or gut, which are areas that interact with the outside world. Studies have pointed to a possible connection between past infections from viruses, such as hepatitis C, herpes simplex, and influenza A, and an increased risk of developing PD. This has raised interest in how environmental factors can trigger PD and how our body's responses to these factors can influence the disease's development.
Two important genes related to PD are LRRK2 and SNCA. Research in mice has shown that these genes respond to infections caused by viruses and bacteria. For instance, a specific alteration in the LRRK2 gene, called the p.G2019S mutation, was found to make infected mice more prone to inflammation. When these mice faced a viral infection, their condition worsened, especially in female mice. In contrast, another version of the LRRK2 gene, called the p.D1994S, seemed to protect mice from the same virus.
Both LRRK2 and SNCA are found in the brain and other parts of the body. However, their specific roles in protecting the body during infections, particularly in the brain versus outside the brain, are not yet fully understood. This study aimed to investigate what happens when the virus is directly injected into the brain of baby mice, focusing on the outcomes related to LRRK2 and SNCA.
Animal Studies
Animal research for this study was done following strict guidelines to ensure humane treatment. Various types of mice were used, genetically modified to include the LRRK2 mutations or the absence of the SNCA gene. All experiments took place in a specialized facility designed to handle potentially dangerous organisms.
Injecting the Virus
Baby mice were given a direct injection of the reovirus T3D, a virus that can cause disease. This was done under anesthesia to minimize stress. After the injection, the mice were monitored for signs of illness and death for up to 14 days. In another set of experiments, some mice were chosen for evaluation of viral levels in the brain and liver after 8 days.
Monitoring Health and Viral Levels
Health was assessed by counting how long each MOUSE lived after the virus injection. Researchers also looked at the amount of virus in the brain and liver to understand how the virus spread in the body. The results showed that neither the p.G2019S nor the p.D1994S versions of the LRRK2 gene affected how the mice reacted in terms of illness or survival after the direct injection of the virus.
Results of the Study
When the data was analyzed, it was found that the mutations in the LRRK2 gene did not change the survival chances or the levels of virus in the infected mice's brains. Therefore, it seems that these specific genetic changes do not contribute to better or worse outcomes when the virus enters the brain directly.
In another part of the study, researchers also looked at mice that did not have the SNCA gene to see if it had any protective effects after the direct brain injection. Similar to the findings with LRRK2, there were no differences in survival or viral levels in these mice compared to the wild-type mice (those with a normal SNCA gene).
What This Means
Overall, these findings suggest that both the LRRK2 and SNCA genes do not directly affect survival or viral levels when a virus is injected straight into the brain. This was unexpected, as these genes had shown a role in controlling infections when the virus entered through the nose. This indicates that their protective roles are more about how the body responds to infections outside the brain rather than inside it.
It's important to note that the mice used in the study were very young and lacked a developed immune system. This means they relied on innate defenses rather than adaptive immunity, which kicks in later in life. Future experiments will look at older mice that have a more developed immune system to provide deeper insights into how these genes operate.
Broader Implications
The study contributes to a larger conversation about how genetic factors, environmental triggers, and immune responses interact, especially in diseases like Parkinson's. It points to the idea that both LRRK2 and SNCA could have important roles outside the brain in defending against infections, which could impact brain health indirectly.
In terms of future research directions, there is potential to look into how different types of infections, various ages, and even hormonal influences can affect these interactions. For example, studying how the viruses affect older mice or using different viruses could enhance understanding of PD's complex nature.
In conclusion, while the focus has often been on how directly linked genes influence diseases, this study reinforces the idea that the body's responses to infections-especially in areas outside the brain-are crucial for understanding conditions like Parkinson's disease. As new research continues to unfold, the hope is to better understand these connections, leading to improved strategies for treatment and prevention of neurodegenerative diseases.
Title: Variants in Lrrk2 and Snca deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice
Abstract: Variants of the leucine-rich repeat kinase-2 (LRRK2) and -synuclein (SNCA) genes are associated with Parkinsons disease risk. We previously demonstrated that two Lrrk2 knock-in variants as well as Snca expression alter survival rates from combined pneumonitis and encephalitis following intranasal inoculation of newborn mice with a double-stranded RNA virus: respiratory-enteric-orphan virus, serotype-3 strain Dearing (reovirus T3D). Here, we examined whether outcomes of direct inoculation of the brain by reovirus T3D, which invariably causes lethal encephalitis within 15 days, would also be modified by variants in Lrrk2 and Snca. When we inoculated newborn mice intracerebrally with 5x102 plaque-forming units of reovirus T3D, we found that, when compared to wild-type littermates, Lrrk2 p.G2019S mutant mice and kinase-dead p.D1994S mutant animals showed the same time-to-death intervals post-infection, revealed no sex difference, and had similar viral titres in the brain. Furthermore, the reduction or absence of endogenous -synuclein also did not alter the course of encephalitis in parallel studies. These outcomes are in contrast to those following the intranasal inoculation paradigm of newborn mice, in which Lrrk2 and wild-type -synuclein were both protective in infection outcomes. Together, these findings suggest that the Parkinsons disease-linked Lrrk2 and Snca genes contribute predominantly to systemic, innate responses by the host following reovirus T3D exposure.
Authors: Michaela O. Lunn, Christopher Rousso, Julianna J. Tomlinson, Earl G. Brown, Michael G. Schlossmacher
Last Update: 2024-09-28 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.09.28.615578
Source PDF: https://www.biorxiv.org/content/10.1101/2024.09.28.615578.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.